How many clinical trials are tracked of delgocitinib?

3 trials are tracked, 3 with published results.

Mode

All Oncology Infectious Disease Neurology Psychiatry Cardiology Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Anesthesiology & Pain Medicine Pulmonology & Critical Care Nephrology Physical Medicine & Rehab Emergency Medicine Urology Ophthalmology Hematology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

delgocitinib

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of delgocitinib

3 trials tracked of delgocitinib: 3 in phase 3 or 4 and 3 with published results. The most-cited published study has 30 citations.

3Trials tracked

3Phase 3 & 4

0Recruiting

3With published results

Phase distribution

Phase 3 3

Phase 3 A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema Completed · 30 cited
Phase 3 Open-label Multi-site Extension Trial in Subjects Who Completed the DELTA 1 or DELTA 2 Trials Completed · 29 cited
Phase 3 Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema Completed · 2 cited

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.